Literature DB >> 12824176

Structure of a c-kit product complex reveals the basis for kinase transactivation.

Clifford D Mol1, Kheng B Lim, Vandana Sridhar, Hua Zou, Ellen Y T Chien, Bi-Ching Sang, Jacek Nowakowski, Daniel B Kassel, Ciarán N Cronin, Duncan E McRee.   

Abstract

The c-Kit proto-oncogene is a receptor protein-tyrosine kinase associated with several highly malignant human cancers. Upon binding its ligand, stem cell factor (SCF), c-Kit forms an active dimer that autophosphorylates itself and activates a signaling cascade that induces cell growth. Disease-causing human mutations that activate SCF-independent constitutive expression of c-Kit are found in acute myelogenous leukemia, human mast cell disease, and gastrointestinal stromal tumors. We report on the phosphorylation state and crystal structure of a c-Kit product complex. The c-Kit structure is in a fully active form, with ordered kinase activation and phosphate-binding loops. These results provide key insights into the molecular basis for c-Kit kinase transactivation to assist in the design of new competitive inhibitors targeting activated mutant forms of c-Kit that are resistant to current chemotherapy regimes.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12824176     DOI: 10.1074/jbc.C300186200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  76 in total

1.  Structural basis for the impact of phosphorylation on the activation of plant receptor-like kinase BAK1.

Authors:  Liming Yan; Yuanyuan Ma; Dan Liu; Xiaochao Wei; Yuna Sun; Xiaoyue Chen; Huadong Zhao; Jingwen Zhou; Zhiyong Wang; Wenqing Shui; Zhiyong Lou
Journal:  Cell Res       Date:  2012-05-01       Impact factor: 25.617

2.  Selective KIT inhibitor KI-328 and HSP90 inhibitor show different potency against the type of KIT mutations recurrently identified in acute myeloid leukemia.

Authors:  Akane Tsujimura; Hitoshi Kiyoi; Yukimasa Shiotsu; Yuichi Ishikawa; Yumiko Mori; Hiroshi Ishida; Tsutomu Toki; Etsuro Ito; Tomoki Naoe
Journal:  Int J Hematol       Date:  2010-10-05       Impact factor: 2.490

3.  Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase.

Authors:  Fahad Zadjali; Ashley C W Pike; Mattias Vesterlund; Jianmin Sun; Chenggang Wu; Shawn S C Li; Lars Rönnstrand; Stefan Knapp; Alex N Bullock; Amilcar Flores-Morales
Journal:  J Biol Chem       Date:  2010-10-28       Impact factor: 5.157

4.  c-kit and its related genes in spermatogonial differentiation.

Authors:  Lei Zhang; Jiangjing Tang; Christopher J Haines; Huai L Feng; Liangxue Lai; Xiaoming Teng; Yibing Han
Journal:  Spermatogenesis       Date:  2011-07-01

5.  Production of selenomethionyl-derivatized proteins in baculovirus-infected insect cells.

Authors:  Ciarán N Cronin; Kheng B Lim; Joe Rogers
Journal:  Protein Sci       Date:  2007-07-27       Impact factor: 6.725

6.  Structural basis for KIT receptor tyrosine kinase inhibition by antibodies targeting the D4 membrane-proximal region.

Authors:  Andrey V Reshetnyak; Bryce Nelson; Xiarong Shi; Titus J Boggon; Alevtina Pavlenco; Elizabeth M Mandel-Bausch; Francisco Tome; Yoshihisa Suzuki; Sachdev S Sidhu; Irit Lax; Joseph Schlessinger
Journal:  Proc Natl Acad Sci U S A       Date:  2013-10-14       Impact factor: 11.205

7.  Drug binding and resistance mechanism of KIT tyrosine kinase revealed by hydrogen/deuterium exchange FTICR mass spectrometry.

Authors:  Hui-Min Zhang; Xiu Yu; Michael J Greig; Ketan S Gajiwala; Joe C Wu; Wade Diehl; Elizabeth A Lunney; Mark R Emmett; Alan G Marshall
Journal:  Protein Sci       Date:  2010-04       Impact factor: 6.725

8.  The juxtamembrane region of the EGF receptor functions as an activation domain.

Authors:  Monica Red Brewer; Sung Hee Choi; Diego Alvarado; Katarina Moravcevic; Ambra Pozzi; Mark A Lemmon; Graham Carpenter
Journal:  Mol Cell       Date:  2009-06-26       Impact factor: 17.970

Review 9.  Impact of the Protein Data Bank on antineoplastic approvals.

Authors:  John D Westbrook; Rose Soskind; Brian P Hudson; Stephen K Burley
Journal:  Drug Discov Today       Date:  2020-02-14       Impact factor: 7.851

Review 10.  The tyrosine kinase network regulating mast cell activation.

Authors:  Alasdair M Gilfillan; Juan Rivera
Journal:  Immunol Rev       Date:  2009-03       Impact factor: 12.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.